jueves, 6 de abril de 2017

Drug Approvals and Databases > Drug Trials Snapshots

Drug Approvals and Databases > Drug Trials Snapshots

FDA Logo
A new  DRUG TRIALS SNAPSHOT is now available.
DUPIXENT is used for treatment of moderate to severe atopic dermatitis in adult patients whose disease is not well controlled with topical therapies, or who cannot use topical therapies (topical therapies are applied directly to the affected areas of the skin).
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.
Drug Trials Snapshots banner

No hay comentarios:

Publicar un comentario